Myeloperoxidase (MPO)-anti-neutrophil cytoplasmic autoantibody (ANCA)-associated necrotizing crescentic glomerulonephritis (NCGN) is characterized by abundant leukocyte infi ltration.
INTRODUCTION
Circulating anti-neutrophil cytoplasmic autoantibodies (ANCA) directed against myeloperoxidase (MPO) are associated with systemic small vessel vasculitis, often characterized by necrotizing crescentic glomerulonephritis (NCGN). 1 In mice, administration of murine anti-MPO antibodies induces an acute glomerular infl ammation that progresses to NCGN within days. 2 This process is aggravated severely upon co-administration of lipopolysaccharide (LPS). 3 Pathologically, the model is characterized by an early glomerular accumulation of neutrophils that progresses to crescentic glomerulonephritis with abundant glomerular and interstitial macrophage infi ltration. Moreover, neutrophils are the main eff ector cells in disease induction, as neutrophil depletion completely prevented disease development. 4 Recruitment of infl ammatory cells to sites of infl ammation is, to a large extent, regulated by chemokines. Chemokines are small chemotactic cytokines that are secreted by activated or injured cells and can be recognized by specifi c G-protein coupled receptors expressed on leukocytes. 5, 6 Chemokines are classifi ed into four families -C, CC, CXC and CX 3 C -according to the position of the fi rst two cysteines in the conserved amino acid sequence. Most chemokines belong to the CXC chemokine family, recruiting neutrophils and T and B cells, or the CC chemokine family, recruiting multiple leukocyte subsets including monocytes and T cells but not neutrophils. CXC chemokines containing an ELR + (glutamic acid-leucine-arginine) motif are particularly powerful chemoattractants for neutrophils. The most potent ELR + CXC chemokine is interleukin (IL)-8 (CXCL8), which binds and activates its receptors CXCR1 and CXCR2 with similar affi nity. CXCR1 is specifi c for IL-8, whereas other ELR + CXC chemokines (CXCL1, 2, 3, 5 and 7) can act through CXCR2. MPO-ANCA can activate neutrophils to produce IL-8, 7, 8 and IL-8 is present in crescentic lesions of ANCA-associated NCGN patients, 7 suggesting a pathogenic role for IL-8 in MPO-ANCA-associated vasculitis. Because a murine ortholog of human IL-8 does not exist, the activities of other ELR + CXC chemokines, e.g. keratinocyte-derived chemokine (KC/CXCL1) and macrophage infl ammatory protein-2 (MIP-2/ CXCL2), are more prominent in mice. CXCR2 is expressed predominantly on neutrophils, but can also be detected on monocytes/macrophages and non-infl ammatory cells, including microvascular endothelial cells. [9] [10] [11] [12] Because of the diversity in chemokine receptors expressed by leukocytes, production of diff erent chemokines during distinct phases of an infl ammatory response determines the recruitment of specifi c leukocyte subsets in time and space. Spatiotemporal analysis of chemokine and chemokine receptor expression patterns during the course of glomerulonephritis may reveal potential targets for intervening in recruitment of specifi c leukocyte subsets. Chemokine and chemokine receptor expression patterns have been analyzed in several glomerulonephritis models, such as nephrotoxic nephritis and immune complex glomerulonephritis (reviewed in references 13 and 14) . No studies have been conducted, however, in experimental models of ANCA-associated vasculitis.
In this study, we analyzed the renal gene expression levels of chemokines and chemokine receptors in the mouse model of anti-MPO-mediated NCGN, both in time and space, to identify potential targets for intervention. Based upon our initial results, we examined specifi cally the role of the chemokine receptor CXCR2 in experimental anti-MPO IgG-induced NCGN using a CXCR2blocking serum.
MATERIALS AND METHODS

Animals
Mpo -/mice were back-crossed to a C57BL/6 background seven times 15 and bred in-house.
Female C57BL/6 wild-type mice were purchased from Harlan (Horst, the Netherlands). All animal experiments were performed according to national guidelines and upon approval of the Animal Care and Use Committee of Groningen University.
Production of polyclonal mouse anti-MPO IgG
Murine MPO was purifi ed from WEHI-3 cells and used for immunization of Mpo -/mice, as described previously. 3 Total IgG was isolated from pooled sera of immunized Mpo -/mice and the anti-MPO titer was checked by enzyme-linked immunosorbent assay (ELISA), as reported previously. 3
Induction and evaluation of anti-MPO IgG-induced NCGN
W ild-type C57BL/6 mice (8-10 weeks) received 100 g/g body weight of anti-MPO IgG intraperitoneally, followed by an intraperitoneal injection with 1500 EU/g (0.5 μg/g) LPS (Escherichia coli, serotype O26:B6; Sigma, St Louis, MO, USA) 1 h later. Mice were killed after 1 or 7 day(s), and kidneys were harvested, cut and partly snap-frozen for gene and protein analyses and partly embedded in paraffi n for histopathological evaluation. Plasma and (17-h) urine were collected at both time-points. Urine samples were tested for hematuria (0-4+ score) by Combur-Test strips (Roche Diagnostics BV, Almere, the Netherlands) and albuminuria by ELISA (Bethyl Laboratories, Montgomery, TX, USA). Periodic acid-Schiff staining was performed on paraffi n sections and the number of glomerular crescents was counted in 100 consecutive glomerular cross-sections in a blinded fashion, as described previously. 16 Immunohistochemical staining for neutrophils was performed on acetone-fi xed 5 μm cryosections using an anti-rabbit peroxidase-based Envision+ system (DakoCytomation, Carpinteria, CA, USA) according to the manufacturer's protocol. Sections were incubated for 30 min with 10 μg/ml rat anti-mouse Ly6G (clone 1A8; BD Biosciences, Breda, the Netherlands) or isotype control antibody (IgG2a; Antigenix America, Huntington Station, NY, USA) followed by a 30-min incubation with 10 μg/ml unlabeled rabbit anti-rat secondary antibody (Vector Laboratories, Burlingame, CA, USA). After detection of peroxidase activity with 3-amino-9ethylcarbazole, sections were counterstained with Mayer's hematoxylin.
Chemokine expression analysis
For chemokine analysis, we studied kidneys from untreated mice (n = 12), mice subjected to LPS for 1.88 ± 0.69 neutrophils/glomerular cross-section; albuminuria 59.0 ± 69.6 μg/16h) and 7 days (n = 14;
19.9 ± 6.6 % crescents; albuminuria 1203 ± 944 μg/16h). For whole kidney gene expression analysis, RNA was isolated using RNeasy mini kit (Qiagen Benelux BV, Venlo, the Netherlands) with DNase I treatment on the column. For analysis of microdissected material, 606 (range 410 -873) glomeruli (equal to 2.72 ± 0.29 x 10 6 μm 2 ) and surrounding tubulo-interstitial tissue (2.88 ± 0.25 x 10 6 μm 2 ) were dissected using the Laser Robot Microbeam System (PALM Micro laser Technology, Bernried, Germany), as described previously 17 , and RNA was isolated using RNeasy micro kit (Qiagen). Reverse transcription was carried out using Superscript III reverse transcriptase (Invitrogen, Breda, the Netherlands) and random hexamer primers (Promega, Leiden, the Netherlands). Gene expression was analyzed with a chemokine-focused 384-well micro fl uidic card, containing primer-probe sets for 48 diff erent genes ( Table 1) 
Cell culture
Human conditionally immortalized glomerular endothelial cells (CiGEnC) 18 were cultured in endothelial growth medium 2-microvascular (EGM2-MV; Cambrex-Lonza, Breda, the Netherlands) containing fetal calf serum (5%) and growth factors as supplied, without vascular endothelial growth factor (VEGF). CiGEnC up to passage 40 were propagated at 33°C (when cells have a proliferative phenotype), whereas experiments were carried out after 5-7 days of incubation at 37°C (nonproliferative/quiescent phenotype.
Gene expression analysis of human glomerular endothelial cells and neutrophils
CiGEnC were seeded in 12-well plates (90 000 cells/well) and incubated at 33°C for 1 day before thermoswitching to 37°C. Neutrophils were isolated from heparinized venous blood of healthy dono rs by density gradient centrifugation on Lymphoprep (Axis-Shield, Oslo, Norway). Erythrocytes were lysed with ice-cold ammonium chloride buff er, and neutrophils were washed in Hanks`s balanced salt solution without Ca 2+ /Mg 2+ (HBSS -/-, Gibco/Life Technologies, Breda, the Netherlands).
RNA was isolated using RNeasy Plus Mini kit (Qiagen), and cDNA was prepared and individual gene real-time PCR analyses were carried out as described in the 'chemokine expression analysis' section. Primer-probe sets specifi c for human CXCR1 (Hs00174146_m1), CXCR2 (Hs00174304_m1) 
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In vivo anti-CXCR2 treatment
The inhibitory goat anti-murine CXCR2 serum was raised against a peptide (MGEFKVDKFNIEDFFSG) of the ligand-binding region of CXCR2. In previous studies, this antiserum (0.5-1.0 ml) has been shown to abrogate neutrophil infl ux in lung infl ammatory mouse models without aff ecting circulating neutrophil numbers. 19, 20 Mice (n = 6/group) received 0.8 ml anti-CXCR2 or normal goat serum (AbD Serotec, Düsseldorf, Germany) intraperitoneally every other day, starting with the fi rst treatment 24h before anti-MPO IgG administration. In a separate experiment, mice (n = 3/group) received a daily dose (30 mg/kg) of the CXCR2-inhibitor repertaxin (Sigma) subcutaneously, starting with the fi rst treatment 1 h before anti-MPO IgG administration, and were killed after 7 days.
Statistical analysis
Statistical signifi cance was determined using one-way analysis of variance (ANOVA) with Bonferroni's multiple comparison test (whole kidney mRNA analysis, intracellular calcium measurements and CXCL1/CXCL2/CXCL5 protein measurements) or two-tailed Student's t-test (mRNA analysis of dissected renal compartments and quantifi cation of glomerular neutrophils). detected; nt, not tested -CXCR4 could not be analyzed due to insuffi cient amplifi cation reactions. Relative mRNA level we determined the localization of chemokine expression by comparing expression levels between laser microdissected glomeruli and the tubulo-interstitial area. We confi rmed accurate separation of the compartments with laser microdissection by analyzing expression of glomerulus-specifi c (podocin and nephrin) and tubulus-restricted (megalin and aquaporin-2) genes (data not shown).
RESULTS
Chemokine and chemokine receptor expression in the acute infl ammatory phase of anti-MPO
IgG induced NCGN
Gene expression analysis of chemokines and chemokine receptors in
We found that gene expression of most of the chemokines and chemokine receptors was localized predominantly in the glomerular compartment (Figure 1f-j) . CCL8, CCL17 and CCL20. In addition, increased expression was observed for the CC-chemokine receptors CCR2 and CCR8 and CXC-chemokine CXCL10. In contrast to day 1, no increased expression of CCL3 and CXCL13 was found at day 7. CXCL1, CXCL2, and CXCL5, the ligands for CXCR2, were also up-regulated in the crescentic phase, although the receptor itself was expressed at a level similar to control mice. Furthermore, CX 3 CL1 and its receptor CX 3 CR1 were expressed to an increased extent. Analysis of dissected renal tissue showed that expression of the majority of chemokines and receptors was also localized in glomeruli at this later time-point (Figure 2f-j) . However, for some chemokines the pattern changed. CXCL2 was expressed highly in glomeruli but less so in the tubulo-interstitium on day 1, while on day 7 no signifi cant diff erence was found.
Chemokine and chemokine receptor expression in the crescentic phase of anti-MPO
Protein expression of CXCR2 and CXCR2 ligands
Because a temporal induction of CXCR2 was detected in the acute phase and induction of its ligands in both the acute and the crescentic phases, we aimed to investigate further the role of CXCR2 and its ligands in anti-MPO IgG-induced NCGN. Analysis of circulating CXCL1 and CXCL2 protein levels demonstrated increased CXCL1 levels in the crescentic phase of anti-MPO IgG-induced NCGN ( Table 2 ). In contrast, CXCL1, CXCL2 and CXCL5 protein levels in renal homogenates did not change during the course of anti-MPO IgG-induced NCGN ( Table 2 ). In addition, we wanted to determine to what extent intrinsic glomerular cells contribute to glomerular CXCR2 expression. Recent data indicate that expression of CXCR2 is not restricted to infl ammatory cells, but can also be detected on microvascular endothelial cells. Furthermore, endothelial CXCR2 has been demonstrated to be involved in LPS-induced neutrophil infi ltration in the lungs. 21 We speculated that CXCR2 was expressed on glomerular endothelial cells and that endothelial CXCR2 could contribute to the early neutrophil accumulation, as observed in anti-MPO/LPS-induced glomerulonephritis. We studied whether human CiGEnC expressed CXCR2. CXCR2 mRNA was detected in CiGEnC, but its expression was much lower compared to expression in human neutrophils (Figure 3a ). CXCR1 mRNA was not detected in CiGEnC. Treatment of CiGEnC with IL-8 induced an intracellular calcium fl ux in approximately 70% of the cells, which was mediated by CXCR2 but not by CXCR1 (Figure 3b ). These results indicate that glomerular endothelial cells express a functional CXCR2 receptor.
In vivo inhibition of CXCR2 does not attenuate renal injury in anti-MPO IgG-induced NCGN
To study the functional role of the CXCR2-CXCR2 ligand axis in anti-MPO IgG/LPS-mediated glomerulonephritis, we blocked the receptor employing a CXCR2 blocking serum. Compared to control-treated mice, mice that had received anti-CXCR2 serum showed an increase in glomerular neutrophil accumulation 1 day after anti-MPO IgG/LPS administration (Figure 4a and b) . Moreover, inhibition of CXCR2 did not change the percentage of glomeruli positive for neutrophils (control 65.7 ± 5.0 and anti-CXCR2 66.3 ± 6.3%) but rather increased the mean number of neutrophils per positive glomerulus (control 1.75 ± 0.30 and anti-CXCR2 2.59 ± 0.50, P < 0.05). Treatment of mice suff ering from anti-MPO IgG-induced NCGN with the anti-CXCR2 blocking serum did not reduce hematuria and albuminuria (Figure 4c and d) . In addition, CXCR2 inhibition did not infl uence glomerular crescent formation, as a similar percentage of crescentic glomeruli was detected in control and anti- 
DISCUSSION
In the present study, we demonstrate spatiotemporal diff erences in chemokine and chemokine receptor gene expression levels in a mouse model of anti-MPO IgG-induced NCGN. Our objective was to identify those chemokines and chemokine receptors whose expression patterns suggest involvement in the recruitment of specifi c leukocyte subsets.
Induction of CXCR2 was restricted to the acute infl ammation phase. Its ligands CXCL1, CXCL2
and CXCL5, were up-regulated in both the acute and crescentic phases of the disease. Our fi ndings suggest that CXCL2 expression is restricted to glomeruli in the acute phase of anti-MPO IgG-induced NCGN, whereas in the crescentic phase CXCL2 is expressed in both the glomerular and the tubulointerstitial compartment, which correlates with the presence of both glomerular and interstitial infl ammatory infi ltrates at this time-point. We chose CXCR2 as an initial target for intervention because the temporal induction of CXCR2 suggested involvement of CXCR2 in recruitment of neutrophils, which are pivotal eff ector cells in anti-MPO IgG-induced NCGN. 4 Furthermore, several studies have demonstrated reduced glomerular neutrophil infl ux and albuminuria in models of glomerulonephritis upon inhibition of CXCR2 or its ligands. [22] [23] [24] [25] The measurements of CXCL1, CXCL2 and CXCL5 protein in kidney tissue did not confi rm the increase in tissue-specifi c expression of these chemokines suggested by analysis of mRNA levels. In plasma, we observed a higher CXCL2 level at day 7. Interestingly, increased circulating levels of IL-8 have been observed in ANCA-associated vasculitis patients. 26 Interestingly, blocking CXCR2 in our model of anti-MPO IgG-induced NCGN did not prevent early glomerular neutrophil infl ux but increased glomerular accumulation of neutrophils. In vitro fl ow assays have revealed that inhibition of neutrophil CXCR2 reduces transendothelial migration of ANCA-activated neutrophils. 27 We speculate that in our experiment neutrophils were recruited to glomeruli via chemoattractants other than CXCR2 ligands but, due to inhibition of CXCR2-mediated transendothelial migration, were retained within the vascular compartment. In line with this, Cockwell et al hypothesized that frustrated neutrophil transmigration due to high levels of intravascular IL-8 contributes to glomerular injury in ANCAassociated glomerulonephritis. 7 The observation that inhibition of CXCR2 accelerated glomerular neutrophil accumulation would also imply a worsening of other disease parameters, but we did not observe increased urinary abnormalities or crescent formation, which was supported by the repertaxin experiment. Based on the experiments conducted, we cannot explain this discrepancy, although our data suggest that the extent of kidney injury is determined primarily by the number of aff ected glomeruli. A probable neutrophil chemoattractant involved in the neutrophil recruitment in anti-MPO IgG-induced NCGN is C5a. Recently, genetic ablation or inhibition of complement factor C5, and consequently C5-derived C5a, was found to abrogate disease development completely in this model 16, 28 . Moreover, neutrophils from CXCR2 -/mice retain chemotactic activity towards C5a. 29 An additional possibility is that the activity of other chemokines and chemokine receptors becomes more important, as there is redundancy in the chemokine system. 30 The obse rved increase in CXCR2 mRNA at day 1 in our disease model is caused most probably by the glomerular infl ux of neutrophils and not by up-regulation of endothelial CXCR2, as neutrophils express relatively high levels of CXCR2. Reutershan and colleagues demonstrated that endothelial CXCR2 was involved in LPS-induced neutrophil transmigration in the lungs. 21 Although lung tissue has a higher expression of CXCR2 compared to kidney, we cannot exclude the possibility that inhibition of endothelial CXCR2 in glomeruli contributed to neutrophil transmigration impairment in our CXCR2-intervention experiment.
Other chemokines that had increased expression in the acute phase were CCL3 and CCL5, suggesting their involvement in leukocyte infl ux. Increased protein levels of CCL3 and CCL5 have been found in vasculitic lesions in lungs of Wegener's granulomatosis. 31 None of the receptors for CCL3 and CCL5 (e.g. CCR1, CCR5), however, were up-regulated in our model.
In the crescentic phase of anti-MPO IgG-induced NCGN, CCR2 was up-regulated and expressed predominantly in glomeruli. The CCR2 ligands CCL2 and CCL7 were also expressed to an increased extent and mainly in glomeruli. Up-regulation of CCR2 and its ligands suggests involvement in the monocyte/macrophage infl ux observed in the crescentic phase of anti-MPO IgG-induced NCGN. Neutralization studies have demonstrated important roles for CCR2 and CCL2 in monocyte/macrophage infl ux and, in some cases, crescent formation in other models of crescentic glomerulonephritis. [32] [33] [34] Furthermore, CCL2 protein has been detected in glomerular and interstitial cells in ANCA-associated vasculitis patients with renal involvement. 35 In addition, we observed upregulation of CX 3 CL1 and its receptor CX 3 CR1 in the crescentic phase. CX 3 CL1 is a transmembrane domain-containing chemokine with monocyte attracting properties. CX 3 CL1 mRNA expression has been observed in glomerular lesions of vasculitic patients, 36 whereas inhibition of CX 3 CR1 in a rat model of crescentic glomerulonephritis attenuated glomerular leukocyte infl ux and reduced crescent formation. 37 These data suggest that CX 3 CL1 may be involved in the pathogenesis of anti-MPO IgG-induced NCGN.
Our fi nding that several chemokines were up-regulated during anti-MPO IgG-induced glomerulonephritis raises questions on the cellular source of chemokine production. We speculate that intrinsic renal (predominantly glomerular) cells are, in part, responsible for the production of chemokines, as are infi ltrating infl ammatory cells. The relative contributions of the diff erent intrinsic glomerular cells -glomerular endothelial cells, podocytes and mesangial cells -in chemokine production could be investigated in vitro in future studies.
In this study, we have used murine anti-MPO IgG-induced glomerulonephritis as a model for human ANCA-associated vasculitis. For the translation of our data to the human situation, it is important to realize that the mouse model mimics ANCA-induced eff ects on neutrophils (and other cells) but does not involve a genuine autoimmune response. In addition, the model encompasses a proinfl ammatory stimulus, which may have modulated expression of chemokines and receptors in a way that does not occur in human ANCA-associated vasculitis.
In conclusion, various chemokine receptors and chemokines, including CXCR2, CCR2 and CX 3 CR1 and their ligands, are up-regulated during the course of anti-MPO IgG-induced NCGN, and they probably contribute to shaping the infl ammatory response. These chemokines and chemokine receptors can be tested further as potential targets in anti-MPO IgG-induced glomerulonephritis.
Inhibition of one potential target, CXCR2, did not diminish anti-MPO IgG-induced NCGN. On the contrary, CXCR2 inhibition may, hypothetically, accelerate the vasculitic process by retaining neutrophils in the vascular compartment. Intervening with multiple chemokine targets is probably necessary to avoid redundancy of the chemokine system.
